Table 5.

Serum levels of sFas and sFasL in normal controls and PLC patients

Group	Case	sFas (µg/L)	sFasL (µg/L)
Normal control	30	22.56 ± 7.82	27.56 ± 7.86
Primary cancer	40	52.18 ± 21.98*	87.12 ± 27.56**
Recurrence	24	108.12 ± 26.78**,##	318.56 ± 140.12**,##

Note: Compared with the normal control group;

^* P<0.05;

^** P<0.01.

Compared with the primary cancer group;

^## P<0.01.